# Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.

> **NCT02795546** · PHASE4 · COMPLETED · sponsor: **Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre** · enrollment: 32 (actual)

## Conditions studied

- Intrabony Periodontal Defect

## Interventions

- **DRUG:** Alendronate sodium
- **BIOLOGICAL:** beta-tricalcium phosphate bone substitute

## Key facts

- **NCT ID:** NCT02795546
- **Lead sponsor:** Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02795546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02795546, "Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02795546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*